NCT01128595
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Wellington, New Zealand
- GSK Investigational Site Gothenburg, Sweden
- GSK Investigational Site Lund, Sweden